Merging empathy with science: solutions for life
WHO WE ARE
Planned 5th mask manufacturing facility in Asia
4th mask manufacturing facility based in China
PIC/S approval in facility manufacturing ODS
3rd mask manufacturing facility based in China
2nd mask manufacturing facility based in China
Seven N95 respirators and masks approved by U.S FDA
Invest in Hart-S, first ODS manufacturing and research
International Procurement & Distribution Service of Medicinal Products
U.S FDA approval of 2 pandemic N95 respirators, second in the world
U.S FDA recommended Pasture F550G and A520G for use to protect against H1N1
NIOSH approval for anti-viral mask, first in the world
Invest in R&D for anti-viral mask
Mask manufacturing facility based in Taiwan
Largest Supplier of Influenza vaccines to Singapore government during SARS
Exclusive distributor of Chiron Vaccines (Novartis)
Exclusive distributor of Genzyme SE Asia (Sanofi)
Incorporation of Pacific Biosciences Singapore
Exclusive Distributor for Byk Gulden (Altana)
Incorporation of Pasture Pharma in Singapore
Attained Halal Certification for Pasture Surgical N95 Respirators for Healthcare and Public Use
5th mask manufacturing facility opened in Thailand
Supplied more than 100 million Surgical N95 Respirators and Masks globally
Exclusive Distributor for CanSino Biologics with single-shot COVID-19 vaccine in Singapore
Board of Directors
Mr. Lloyd SoongExecutive Chairman and Chief Executive Officer
Lloyd Soong, CEO and Director of Pasture Holdings
Mr. Soong founded the Group in 1996 after seeing an unmet need for a distribution company that focused on specialty medications and medical devices. He oversees the overall business, operations, and performance of the Group. He has over 39 years of experience in the pharmaceutical and medical supplies and devices industry. Mr. Soong has a Master of Business Administration (Strategic Marketing) from the University of Hull, England. Lloyd’s personal interests are rooted in the R&D of innovative products that can improve one’s quality of life.
Mr. Prashanth PalepuNon-Executive Director
Mr. Prashanth Palepu
Mr. Palepu is currently the chief operating officer of Palepu Pharma, where he spearheads developments within the supply chain process. He is a member of the Entrepreneurs Organisation in India, a global platform for entrepreneurs. Mr. Palepu has a Bachelor of Commerce from Loyola College, and a Master of Science in Supply Chain and Logistics Management from the University of Warwick.
Mr. Michael LimNon-Executive and Lead Independent Director
Mr. Michael Lim
Non-Executive and Lead Independent Director
Mr. Lim is currently the chief financial officer of Fuelcore Pte. Ltd. He has over 30 years of experience in corporate finance, corporate restructuring and tax planning. Mr. Lim completed his professional education with the Institute of Chartered Accountants in England and Wales.
Ms. Claudia TeoNon-Executive and Independent Director
Ms. Claudia Teo
Non-Executive and Independent Director
Ms. Claudia Teo is a Non-Executive and Independent Director and was appointed to our Board on 29 March 2023.
Ms. Teo is currently the head of the corporate and financial services practice group in Harry Elias Partnership LLP (“HEP”). She has over 20 years of experience in advising on landmark transactions in corporate finance, including initial public offerings on the SGX-ST, placements and rights issues, privatisations, compliance and corporate governance issues. Ms. Teo joined HEP in 2006 where her main areas of practice are in corporate finance and mergers and acquisitions transactions throughout Asia.
Between June 2015 to October 2021, Ms. Teo served as an independent non-executive director of an SGX Catalist listed company, where she served as the chairperson of the nominating committee and the risk management committee, and was also a member of the audit committee and remuneration committee.
Ms. Teo was recommended in the 2015 edition of the Legal 500 Asia-Pacific and also in the 2014 edition of Asialaw’s Leading Lawyer publication. Ms. Teo is also a non-executive director and a member of the investment committee and the governance and risk committee of Ren Ci Hospital, a Singapore charity healthcare institution. She is also a member of the investment committee of Singapore Hokkien Huay Kuan and an independent director of The Hokkien Foundation.
Ms. Teo completed her Bachelor of Laws (Hons) at the University of Manchester. She is dually qualified as a barrister and a solicitor of England and Wales and is admitted to the Rolls of Solicitors of Hong Kong. Ms. Teo was called to the Singapore Bar in 1990.
Ms. Sharon LowNon-Executive and Independent Director
Ms. Sharon Low
Ms. Low is a biochemist and entrepreneur. She worked on animal vaccines at NUS research laboratories and subsequently was founder and Managing Director of stem cell service company StemLife Berhad, where she led regional growth initiatives as well as its public listing and strategic sale. She currently serves as a non-executive director of KRZ Limited (HK). Ms. Low has a Bachelor of Science with honors in Biochemistry, Molecular Biology & Biotechnology from the University of Bristol, UK.
Mr. Titus CheongChief Financial Officer
Mr. Titus Cheong
Chief Financial Officer
Mr. Cheong oversees a wide range of responsibilities in the Group, including the finance, mergers & acquisitions, corporate social responsibility, and compliance and governance operations. He is a director at Mercy Relief Limited. Mr. Cheong has a Bachelor of Commerce from the University of Toronto.
Ms. Claire SoongAlternate Director to Lloyd Soong and Digital Marketing Manager
Ms. Claire Soong
Alternate Director to Lloyd Soong
Digital Marketing Manager
Ms. Soong has a Bachelor of Commerce from McGill University. She is the Group’s Digital Marketing Manager, overseeing the digitalization, marketing, and “furlife” mobile application. Prior to joining the Group, she was a content strategist at Maker Lab for Google APAC.
Ms. Ho Huey-YiChief Pharmacist
Ms. Ho Huey-Yi
Ms. Ho is responsible for managing the pharmaceutical regulatory affairs for our Group, including controlled drugs management and quality management. She also manages the Group’s daily business operations. Ms. Ho has over 19 years of experience in the pharmaceutical industry. She has a Bachelor of Science (Pharmacy) from the National University of Singapore, and has been certified as a registered pharmacist by the Singapore Pharmacy Board.
ERP Implementation Success Stories from AFON
Pasture Pharma Boosts Sales Turnover by 100%; Improves Order and Inventory Tracking
ERP Implementation Success Stories from AFON
Pasture Pharma Boosts Turnover by 100%; Improves Order and Inventory Tracking